12:00 AM
Feb 07, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CVac: Phase IIb ongoing

An independent DSMB recommended continuation of an open-label, Australian and U.S. Phase IIb trial based on safety data from the first 7 patients that showed no safety concerns after the first vaccination with...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >